cb5b00302_si_001.pdf (530.05 kB)
Download file

Structural Insight into Multivalent Galactoside Binding to Pseudomonas aeruginosa Lectin LecA

Download (530.05 kB)
journal contribution
posted on 20.11.2015, 00:00 authored by Ricardo Visini, Xian Jin, Myriam Bergmann, Gaelle Michaud, Francesca Pertici, Ou Fu, Aliaksei Pukin, Thomas R. Branson, Dominique M. E. Thies-Weesie, Johan Kemmink, Emilie Gillon, Anne Imberty, Achim Stocker, Tamis Darbre, Roland J. Pieters, Jean-Louis Reymond
Multivalent galactosides inhibiting Pseudomonas aeruginosa biofilms may help control this problematic pathogen. To understand the binding mode of tetravalent glycopeptide dendrimer GalAG2 [(Gal-β-OC6H4CO-Lys-Pro-Leu)4(Lys-Phe-Lys-Ile)2Lys-His-Ile-NH2] to its target lectin LecA, crystal structures of LecA complexes with divalent analog GalAG1 [(Gal-β-OC6H4CO-Lys-Pro-Leu)2Lys-Phe-Lys-Ile-NH2] and related glucose-triazole linked bis-galactosides 3u3 [Gal-β-O­(CH2)n-(C2HN3)-4-Glc-β-(C2HN3)-[β-Glc-4-(N3HC2)]2-(CH2)n-O-β-Gal (n = 1)] and 5u3 (n = 3) were obtained, revealing a chelate bound 3u3, cross-linked 5u3, and monovalently bound GalAG1. Nevertheless, a chelate bound model better explaining their strong LecA binding and the absence of lectin aggregation was obtained by modeling for all three ligands. A model of the chelate bound GalAG2·LecA complex was also obtained rationalizing its unusually tight LecA binding (KD = 2.5 nM) and aggregation by lectin cross-linking. The very weak biofilm inhibition with divalent LecA inhibitors suggests that lectin aggregation is necessary for biofilm inhibition by GalAG2, pointing to multivalent glycoclusters as a unique opportunity to control P. aeruginosa biofilms.